Showing results (221-230 of 380) with videos related to

Sort By:
Pageof 38
Frontiers in Immunology|August 1, 2020
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1Andrea Botticelli, Silvia Mezi, Giulia Pomati, et al.
Clinical Nutrition ESPEN|July 25, 2024
Evaluation of five nutritional scores as predictors of postoperative outcome following pancreatic resection: A prospective, single-center studySalvatore Paiella, Erica Secchettin, Danila Azzolina, et al.
Anti-Cancer Drugs|August 25, 2016
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancerAdriana Romiti, Michela Roberto, Chiara D'Antonio, et al.
Sarcoma|June 4, 2008
Lack of Activity of Docetaxel in Soft Tissue Sarcomas: Results of a Phase II Study of the Italian Group on Rare TumorsA Santoro, A Romanini, A Rosso, et al.
Annals of Surgical Oncology|October 13, 2022
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal AdenocarcinomaLaura Maggino, Giuseppe Malleo, Stefano Crippa, et al.
Toxics|January 20, 2023
Size-Resolved Redox Activity and Cytotoxicity of Water-Soluble Urban Atmospheric Particulate Matter: Assessing Contributions from Chemical ComponentsAthanasios Besis, Maria Pia Romano, Eleni Serafeim, et al.
Annals of Surgery|December 4, 2023
Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 PatientsStefano Crippa, Giuseppe Malleo, Serena Langella, et al.
Neuropsychobiology|August 16, 2018
Tryptophan and Kynurenine Metabolites: Are They Related to Depression?Maurizio Pompili, Luana Lionetto, Martina Curto, et al.
Anti-Cancer Drugs|November 16, 2016
5-Fluorouracil degradation rate could predict toxicity in stages II-III colorectal cancer patients undergoing adjuvant FOLFOXConcetta E Onesti, Andrea Botticelli, Marco La Torre, et al.
Neuropharmacology|February 26, 2014
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in miceFrancesco Fazio, Cristina Zappulla, Serena Notartomaso, et al.
Pageof 38